Anti-PD drugs and neuroleptics Flashcards

1
Q

Describe the synthesis of dopamine?

A

L-tyrosine (1)L-DOPA  (2)  Dopamine (DA)
This process utilises the enzymes:
(1) Tyrosine hydroxylase
(2) DOPA decarboxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the metabolism of dopamine?

A

DA removed from synaptic cleft by dopamine transporter (DAT) and noradrenaline transporter (NET)

Three enzymes metabolise DA:
Monoamine oxidase A (MAO-A): metabolises DA, NE and 5-HT
MAO-B: metabolises DA
Catechol-O-methyl transferase (COMT): wide distribution, metabolises all catecholamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 4 dopaminergic pathways?

A

Nigrostriatal pathway - susbstantia nigra pars compacta (SNc) to the striatum. Inhibition results in movement disorders

Mesolimbic pathway - ventral tegmental area (VTA) to the Nucleus Accumbens (NAcc). Brain reward pathway.

Mesocortical pathway - VTA to the cerebrum. Important in executive functions & complex behavioural patterns.

Tuberoinfundibular pathway - arcuate nucleus to the median eminence. Inhibition results in hyperprolactinaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the pathophysiology of Parkinson’s disease?

A

Severe loss of dopaminergic projection cells in SNc
Lewy bodies and neurites- Found respectively within neuronal cell bodies and axons
Consist of abnormally phosphorylated neurofilaments, ubiquitin and synuclein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the clinical presentation of PD?

A

Motor symptoms: resting tremor, bradykinesia, rigidity, postural instability (cardinal symptoms)
Autonomic nervous system effects: olfactory deficits, orthostatic hypotension, constipation
Neuropsychiatric: sleep disorders, memory deficits, depression, irritability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is dopamine replacement used to treat PD?

A

Give Levadopa (L-DOPA). You skip tyrosine hydroxylase as its rate imiting
Rapidly converted to DA by DOPA decarboxylase (DOPA-D). Can cross blood-brain barrier (BBB). Peripheral breakdown by DOPA-D 
Leads to nausea and vomiting
Long-term side-effects: dyskinesias and ‘on-off’ effects. NOT disease-modifying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What adjuncts do you give with it?

A

DOPA decarboxylase inhibitors: Carbidopa and Benserazide
Do not cross BBB prevent peripheral breakdown of levodopa so reduce required levodopa dosage

COMT inhibitors: Entacapone & Tolcapone
Increase amount of levodopa in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can you classify the dopamine receptor types?

A

Dopamine (DA) can act on D1,5(Gs linked) or D2-4 (Gi-linked) receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe use of 2 types of dopamine receptor agonists to treat PD?

A

Ergot derivatives: Bromocriptine and Pergolide
Act as potent agonists of D2 receptors
Associated with cardiac fibrosis

Non-ergot derivatives: Ropinirole and Rotigotine
Ropinirole also available as extended-release formulation
Rotigotine also available as a patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the use of Monoamine oxidase B inhibitors in treating PD?

A

Selegiline (deprenyl) and Rasagiline
Reduce the dosage of L-DOPA required
Can increase the amount of time before levodopa treatment is required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How can you classify the symptoms of schizophrenia?

A

Positive symptoms
Hallucinations: Auditory and visual
Delusions: Paranoia
Thought disorder: Denial about oneself

Negative symptoms
Affective flattening: lack of emotion
Alogia: lack of speech
Avolition/ apathy: loss of motivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the correlates of these classifications?

A

Positive symptoms: increased mesolimbic dopinamergic activity
Negative symptoms: Dereased mesocortical dopinamergic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe 2 first generation anti-psychotics?

A

Chlorpromazine
Primary mechanism of action: possibly D2 receptor antagonism
Side effects:
High incidence - anti-cholinergic, especially sedation through muscarinic antagonism
Low incidence - extrapyramidal side-effects (EPS)

Haloperidol
Very potent D2 antagonist 
Therapeutic effects develop over 6-8 weeks
Little impact on negative symptoms
Side effects: High incidence - EPS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe 3 second generation anti-psychotics?

A

Clozapine
Most effective antipsychotic
Very potent antagonist of 5-HT2A receptors
Only drug to show efficacy in treatment resistant schizophrenia & negative symptoms
Side effects: fatal neutropenia, agranulocytosis, myocarditis & weight gain

Risperidone
Very potent antagonist of 5-HT2A & D2 receptors
Side effects: More EPS & hyperprolactinaemia than other atypical antipsychotics

Quetiapine
Very potent antagonist of H1 receptors
Side effects: Lower incidence of EPS than other antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe a partial D2 agonist used in treating schizophrenia

A

Partial agonists theroised in leveliing out increased mesolimbic and decreased mesocortical so treat both sets of symptoms.

Aripiprazole
No more efficacious than typical antipsychotics
Side effects: Reduced incidences of hyperprolactinaemia & weight gain than other antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly